Akso Health Group
8 hedge funds and large institutions have $319K invested in Akso Health Group in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
47% more capital invested
Capital invested by funds: $216K → $319K (+$102K)
33% more funds holding
Funds holding: 6 → 8 (+2)
0.01% more ownership
Funds ownership: 0.05% → 0.05% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$18.1K |
| 2 |
CCG
Catalina Capital Group
Torrance,
California
|
+$16.7K |
| 3 |
GM
GeoWealth Management
Chicago,
Illinois
|
+$7.52K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$13.3K |
| 2 |
BlackRock
New York
|
-$953 |
AHG Hedge Fund Activity: Q4 2024 in Review
8 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q4 2024, worth a combined $319K — up 47% from $216K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new AHG positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $18.1K. The largest seller was Renaissance Technologies, cutting an estimated $13.3K.
- 8 institutional investors held Akso Health Group (AHG) as of Q4 2024, up from 6 in Q3 2024.
- Funds reported $319K of Akso Health Group stock for Q4 2024, up 47% quarter-over-quarter.
- 2 funds opened new Akso Health Group positions in Q4 2024 and 0 closed out, a net change of +2 holders.
- The largest Akso Health Group buyer in Q4 2024 was Millennium Management, an estimated $18.1K added.
- The largest Akso Health Group seller in Q4 2024 was Renaissance Technologies, an estimated $13.3K sold.
Based on aggregated 13F filings for Q4 2024.